Other
Contract With Customer Liability Revenue Recognized
West Pharmaceutical Services Contract With Customer Liability Revenue Recognized increased by 126.5% to $23.1M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 26.2%, from $18.3M to $23.1M.
Analysis
StatementCash Flow Statement
SectionOther
First reportedQ1 2018
Last reportedQ1 2026Apr 23, 2026
Metric ID:
other_contract_with_customer_liability_revenue_recognizedHistorical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11M | $1.6M | $9.7M | $7.8M | $6.1M | $21.3M | $6.1M | $5.8M | $15.5M | $8.7M | $8.6M | $18.3M | $10.8M | $10.2M | $23.1M |
| QoQ Change | — | -85.5% | +506.3% | -19.6% | -21.8% | +249.2% | -71.4% | -4.9% | +167.2% | -43.9% | -1.1% | +112.8% | -41.0% | -5.6% | +126.5% |
| YoY Change | — | — | — | -29.1% | +281.3% | +119.6% | -21.8% | -4.9% | -27.2% | +42.6% | +48.3% | +18.1% | +24.1% | +18.6% | +26.2% |
Range$1.6M – $23.1M
CAGR+23.6%
Avg YoY Growth+41.3%
Median YoY Growth+21.4%
Contract With Customer Liability Revenue Recognized at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's contract with customer liability revenue recognized?
- West Pharmaceutical Services (WST) reported contract with customer liability revenue recognized of $23.1M in Q1 2026.
- How has West Pharmaceutical Services's contract with customer liability revenue recognized changed year-over-year?
- West Pharmaceutical Services's contract with customer liability revenue recognized increased by 26.2% year-over-year, from $18.3M to $23.1M.